Understanding OUR Cytokine-Based Immunotherapy Candidates Our determination extends to advancing a robust portfolio of programs aimed toward increasing the horizons of cytokine-based immunotherapy, especially for cancers where remedy alternatives remain limited. Use the links below to learn a lot more about our portfolio of cytokine-based immunotherapy candidates. Check out https://financefeeds.com/capital-com-taps-lsegs-financial-intelligence/